StockData
Can-Fite BioPharma Ltd. logo

Can-Fite BioPharma Ltd. (CANF) stock

CANFNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 26, 2026Score 1/30
$1.51−0.02 (-1.31%)

Close on Nov 18, 2026Market cap $1.98MP/E –Yield –

Can-Fite BioPharma shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

For fiscal 2025 it was 2M, up 127.0% from the year before. Over ten years it grew 239.9% a year on average. The highest annual figure on record is 2M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 20252M+127.0%
FY2024Dec 31, 20241M+70.2%
FY2023Dec 31, 20230M+56.7%
FY2022Dec 31, 20220M+47.5%
FY2021Dec 31, 20210M+54.3%
FY2020Dec 31, 20200M+317.2%
FY2019Dec 31, 20190M+120.8%
FY2018Dec 31, 20180M+19.6%
FY2017Dec 31, 20170M+17.5%
FY2016Dec 31, 20160M+115287.5%
FY2015Dec 31, 20150M–

More Can-Fite BioPharma figures

See a number that looks wrong?